Update on the use of etanercept across a spectrum of rheumatoid disorders

by Bernard Combe
Published 2008-06-01

Should we stop methotrexate or not for vaccination?

by Patrick Durez, Bernard Combe
Published 2023-04-01

Glucocorticoids in rheumatoid arthritis: current status and future studies

by Frank Buttgereit, Charlotte Hua, Bernard Combe
Published 2020-05-01

Cytomegalovirus infection: friend or foe in rheumatoid arthritis?

by Jean-Luc Davignon, Bernard Combe, Alain Cantagrel
Published 2021-01-01

Occurrence of anterior uveitis in patients with spondyloarthritis treated with tumor necrosis factor inhibitors: comparing the soluble receptor to monoclonal antibodies in a large...

by Gisèle Khoury, Jacques Morel, Bernard Combe, Cédric Lukas
Published 2020-04-01

IL-10 Producing B Cells Ability to Induce Regulatory T Cells Is Maintained in Rheumatoid Arthritis

by Julie Mielle, Julie Mielle, Julie Mielle, Rachel Audo, Rachel Audo, Rachel Audo, Michael Hahne, Michael Hahne, Laurence Macia, Bernard Combe, Bernard Combe, Bernard Combe, Jacques Morel, Jacques Morel, Jacques Morel, Claire Daien, Claire Daien, Claire Daien
Published 2018-05-01

Phosphatidylserine Outer Layer Translocation Is Implicated in IL-10 Secretion by Human Regulatory B Cells.

by Rachel Audo, Charlotte Hua, Michael Hahne, Bernard Combe, Jacques Morel, Claire I Daien
Published 2017-01-01

Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory disease

by Claire Rempenault, Bernard Combe, Jacques Morel, Philippe Guilpain, Cédric Lukas, Claire Immediato Daïen, Léa Tardivon
Published 2024-02-01

Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort

by Gaël Mouterde, Nathalie Rincheval, Cédric Lukas, Claire Daien, Alain Saraux, Philippe Dieudé, Jacques Morel, Bernard Combe
Published 2019-06-01

Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort

by Cédric Lukas, Julia Mary, Michel Debandt, Claire Daïen, Jacques Morel, Alain Cantagrel, Bruno Fautrel, Bernard Combe
Published 2019-11-01

Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis

by Bernard Combe, Proton Rahman, Hideto Kameda, Juan D. Cañete, Gaia Gallo, Noah Agada, Wen Xu, Mark C. Genovese
Published 2020-01-01

Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis

by Bernard Combe, Robin Besuyen, Antonio Gómez-Centeno, Tsukasa Matsubara, Juan José Sancho Jimenez, Zhaoyu Yin, Maya H. Buch
Published 2022-10-01

Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational study

by Bernard Combe, Rene-Marc Flipo, Alain Saraux, Francis Fagnani, Jacques Massol, Gabrielle Cukierman, Jean-Michel Joubert, Philippe Huot-Marchand
Published 2020-05-01

The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies

by Clifton O. Bingham, David Walker, Peter Nash, Susan J. Lee, Lei Ye, Hao Hu, Javaria Mona Khalid, Bernard Combe
Published 2022-01-01

Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combination

by Olivier Vittecoq, Clément Guillou, Julie Hardouin, Baptiste Gerard, Francis Berenbaum, Arnaud Constantin, Nathalie Rincheval, Bernard Combe, Thierry Lequerre, Pascal Cosette
Published 2022-03-01

Distinction and prognosis of early arthritis phenotypes: an analysis in three European cohorts

by Sofia Ramiro, Robert Landewé, Annette van der Helm-van Mil, Alexandre Sepriano, Bernard Combe, Alison Kent, Dirkjan van Schaardenburg, Bastiaan van Dijk, Elsa Mateus
Published 2023-10-01

Ixekizumab, with or without concomitant methotrexate, improves signs and symptoms of PsA: week 52 results from Spirit-P1 and Spirit-P2 studies

by Bernard Combe, Tsen-Fang Tsai, J. Eugene Huffstutter, Aubrey Trevelin Sprabery, Chen-Yen Lin, So Young Park, Andris Kronbergs, Matthew M. Hufford, Peter Nash
Published 2021-01-01

Sodium excretion is higher in patients with rheumatoid arthritis than in matched controls.

by Sarah Marouen, Guilhem du Cailar, Rachel Audo, Cedric Lukas, Gaelle Vial, Anne Tournadre, Emmanuel Barrat, Jean Ribstein, Bernard Combe, Jacques Morel, Claire I Daien
Published 2017-01-01

Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort

by Renaud Felten, Thibaut Fabacher, Nathanaël Sedmak, Jean Sibilia, Christelle Sordet, Emmanuel Chatelus, Francis Berenbaum, Bernard Combe, Adeline Ruyssen-Witrand, Olivier Vittecoq, Nicolas Meyer, Jacques-Eric Gottenberg
Published 2024-03-01

PhosphoLipid transfer protein (PLTP) exerts a direct pro-inflammatory effect on rheumatoid arthritis (RA) fibroblasts-like-synoviocytes (FLS) independently of its lipid transfer ac...

by Rachel Audo, Valérie Deckert, Claire I Daien, Hélène Che, Jamila Elhmioui, Stéphanie Lemaire, Jean-Paul Pais de Barros, Catherine Desrumaux, Bernard Combe, Michael Hahne, Laurent Lagrost, Jacques Morel
Published 2018-01-01